CureMetrix

CureMetrix is an AI medical imaging tool for mammography that helps radiologists triage, mark, and score suspicious lesions and detect breast arterial calcifications to improve clinical workflow and diagnostic accuracy.

Pricing Model: Paid

Category: Health and Wellness Ai Tools

https://curemetrix.com/

Release Date: 29/01/2014

• AI triage to prioritize suspicious mammogram cases
• Automated marking and scoring of lesions on mammograms
• Detection of breast arterial calcifications (BAC) from screening images
• Integration with full-field digital mammography (FFDM) and DBT modalities
• Configurable sensitivity thresholds to match clinical risk tolerances
• Workflow acceleration via sorting and distribution of cases
• Reduction of false positives and recall rates
• Longitudinal tracking of lesion scores over time
• Compatibility with major mammography platforms (e.g. GE, Hologic)
• Visualization overlays that highlight regions of interest for radiologists

CureMetrix is an AI-driven medical imaging solution focused on improving breast health diagnostics through advanced mammography tools. It leverages artificial intelligence to assist radiologists in detecting, triaging, and characterizing suspicious findings in mammograms, while also delivering insight into vascular health via breast arterial calcification detection.

At its core, CureMetrix offers a triage engine (cmTriage) that automatically sorts mammogram studies, pushing those with higher suspicion to the top of the radiologist’s worklist. This allows clinicians to focus first on cases that may require urgent attention. It also supports distribution across multiple readers in larger practices, helping optimize workflow throughput. Alongside triage, the tool uses a lesion‑marking AI (cmAssist) to highlight regions of interest on images and assign a risk score (neuscore) to each mark. Over time, radiologists can observe whether a feature is stable, progressing, or resolving.

A distinctive feature of CureMetrix is cmAngio, which detects breast arterial calcifications (BAC) on screening mammograms—an incidental yet clinically relevant finding linked with cardiovascular risk. By detecting BAC on routine mammograms (without extra radiation), radiologists can add valuable cardiovascular context to a breast imaging session.

CureMetrix’s tools are designed to integrate into existing radiology systems and major imaging platforms, supporting full‑field digital mammography (FFDM) and digital breast tomosynthesis (DBT). Sensitivity thresholds are configurable, letting clinics balance between flagging more cases or reducing false alarms. The system also helps reduce unnecessary recall rates, thereby improving patient experience and lowering system burdens.

Because it aids in early detection and accelerates reading times, CureMetrix holds promise for better clinical outcomes and cost efficiencies. It is positioned not as a replacement for radiologists, but as a support layer—an “AI partner” that augments human expertise. As regulatory approvals expand and platform compatibility increases, CureMetrix aims to make AI a routine part of breast imaging and cardiovascular screening in women’s health care.

Alternative to CureMetrix